loading
전일 마감가:
$7.46
열려 있는:
$7.46
하루 거래량:
93,028
Relative Volume:
0.62
시가총액:
$259.23M
수익:
$21.25M
순이익/손실:
$-16.05M
주가수익비율:
-12.44
EPS:
-0.61
순현금흐름:
$-17.14M
1주 성능:
-2.32%
1개월 성능:
-0.39%
6개월 성능:
-14.91%
1년 성능:
+34.81%
1일 변동 폭
Value
$7.35
$7.63
1주일 범위
Value
$7.35
$7.8423
52주 변동 폭
Value
$4.68
$9.92

Fennec Pharmaceuticals Inc Stock (FENC) Company Profile

Name
명칭
Fennec Pharmaceuticals Inc
Name
전화
(919) 636-4530
Name
주소
PO BOX 13628, RESEARCH TRIANGLE PARK, NC
Name
직원
32
Name
트위터
@FennecPharma
Name
다음 수익 날짜
2025-03-10
Name
최신 SEC 제출 서류
Name
FENC's Discussions on Twitter

FENC을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
FENC
Fennec Pharmaceuticals Inc
7.59 254.79M 21.25M -16.05M -17.14M -0.61
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
441.36 111.36B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
733.04 77.98B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ARGX
Argen X Se Adr
800.01 50.33B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
359.27 47.46B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ONC
Beone Medicines Ltd Adr
338.19 37.43B 4.98B 69.59M 525.67M 0.5197

Fennec Pharmaceuticals Inc Stock (FENC) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2026-01-09 개시 Piper Sandler Overweight
2022-11-22 업그레이드 Cantor Fitzgerald Neutral → Overweight
2022-09-07 개시 CapitalOne Overweight
2022-08-08 재개 Craig Hallum Buy
2020-06-05 개시 Cantor Fitzgerald Overweight
2018-10-11 개시 Goldman Buy
모두보기

Fennec Pharmaceuticals Inc 주식(FENC)의 최신 뉴스

pulisher
Jan 17, 2026

Behavioral Patterns of FENC and Institutional Flows - Stock Traders Daily

Jan 17, 2026
pulisher
Jan 17, 2026

Wall Street Zen Downgrades Adherex Technologies (NASDAQ:FENC) to Buy - Defense World

Jan 17, 2026
pulisher
Jan 16, 2026

Buyback Watch: What is the long term forecast for Fennec Pharmaceuticals Inc stockJuly 2025 Fed Impact & Low Risk Entry Point Guides - baoquankhu1.vn

Jan 16, 2026
pulisher
Jan 16, 2026

Adherex Technologies Inc. (NASDAQ:FENC) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Jan 16, 2026
pulisher
Jan 16, 2026

Adherex Technologies Inc. (NASDAQ:FENC) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World

Jan 16, 2026
pulisher
Jan 16, 2026

(FRX) Market Insights and Trading Signals (FRX:CA) - Stock Traders Daily

Jan 16, 2026
pulisher
Jan 15, 2026

Fennec Pharmaceuticals (TSE:FRX) Share Price Passes Below Fifty Day Moving AverageHere's What Happened - MarketBeat

Jan 15, 2026
pulisher
Jan 13, 2026

Fennec Pharmaceuticals (TSX:FRX) Price Target Increased by 10.41% to 21.57 - Nasdaq

Jan 13, 2026
pulisher
Jan 10, 2026

(FRX) Strategic Investment Report (FRX:CA) - Stock Traders Daily

Jan 10, 2026
pulisher
Jan 10, 2026

Adherex Technologies (NASDAQ:FENC) Now Covered by Piper Sandler - Defense World

Jan 10, 2026
pulisher
Jan 09, 2026

How Fennec Pharmaceuticals Inc. stock reacts to bond yieldsJuly 2025 Spike Watch & Smart Investment Allocation Insights - Улправда

Jan 09, 2026
pulisher
Jan 09, 2026

Piper Sandler initiates Fennec Pharmaceuticals stock with Overweight rating By Investing.com - Investing.com Nigeria

Jan 09, 2026
pulisher
Jan 09, 2026

Piper Sandler initiates Fennec Pharmaceuticals stock with Overweight rating - Investing.com India

Jan 09, 2026
pulisher
Jan 08, 2026

Can Fennec Pharmaceuticals Inc. (RV41) stock stage a strong rebound this quarterJuly 2025 Fed Impact & AI Forecast for Swing Trade Picks - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Is Fennec Pharmaceuticals Inc. (RV41) stock attractive for growth fundsEarnings Miss & Safe Entry Point Identification - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Is Fennec Pharmaceuticals Inc. (RV41) stock a safe buy pre earningsJuly 2025 Patterns & Stepwise Entry and Exit Trade Signals - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Published on: 2026-01-08 23:30:09 - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Can Fennec Pharmaceuticals Inc. stock continue upward trendJuly 2025 Update & Weekly High Momentum Picks - Улправда

Jan 08, 2026
pulisher
Jan 07, 2026

(FRX) Investment Performance Report (FRX:CA) - Stock Traders Daily

Jan 07, 2026
pulisher
Jan 06, 2026

Positive Signs As Multiple Insiders Buy Fennec Pharmaceuticals Stock - Yahoo Finance

Jan 06, 2026
pulisher
Jan 04, 2026

(FRX) Pivots Trading Plans and Risk Controls (FRX:CA) - Stock Traders Daily

Jan 04, 2026
pulisher
Jan 03, 2026

Aug Final Week: Is Fennec Pharmaceuticals Inc RV41 stock undervalued by metricsTrade Volume Report & Weekly High Return Stock Forecasts - moha.gov.vn

Jan 03, 2026
pulisher
Jan 02, 2026

Is Fennec Pharmaceuticals Inc RV41 a good long term investmentStock Split Announcements & High Profit Portfolio Growth - earlytimes.in

Jan 02, 2026
pulisher
Jan 02, 2026

Fennec Pharmaceuticals Inc (TSX:FRX) Slipped Under Its Trend Key Levels Matter - Kalkine Media

Jan 02, 2026
pulisher
Jan 01, 2026

(FRX) On The My Stocks Page (FRX:CA) - Stock Traders Daily

Jan 01, 2026
pulisher
Jan 01, 2026

Fennec Pharmaceuticals (TSE:FRX) Stock Price Passes Below 50-Day Moving AverageHere's Why - MarketBeat

Jan 01, 2026
pulisher
Jan 01, 2026

Fennec Pharmaceuticals (TSE:FRX) Stock Price Passes Below 50-Day Moving Average – Here’s Why - Defense World

Jan 01, 2026
pulisher
Dec 31, 2025

Aug Opening: Can Fennec Pharmaceuticals Inc RV41 stock stage a strong rebound this quarterPortfolio Gains Summary & Safe Swing Trade Setups - Bộ Nội Vụ

Dec 31, 2025
pulisher
Dec 30, 2025

Adherex Technologies (NASDAQ:FENC) Major Shareholder Southpoint Capital Advisors Lp Sells 1,000,000 Shares of Stock - Defense World

Dec 30, 2025
pulisher
Dec 29, 2025

(FRX) Proactive Strategies (FRX:CA) - Stock Traders Daily

Dec 29, 2025
pulisher
Dec 29, 2025

Southpoint Capital Advisors Lp Sells 1,000,000 Shares of Adherex Technologies (NASDAQ:FENC) Stock - MarketBeat

Dec 29, 2025
pulisher
Dec 29, 2025

Fennec Pharmaceuticals Says Southpoint Capital Sold 1 Million Shares - MarketScreener

Dec 29, 2025
pulisher
Dec 28, 2025

Southpoint trims stake in Fennec Pharmaceuticals to 8% - MSN

Dec 28, 2025
pulisher
Dec 27, 2025

Southpoint holdings in Fennec Pharmaceuticals Inc. (TSX: FENC) - The Manila Times

Dec 27, 2025
pulisher
Dec 26, 2025

Southpoint Capital Advisors controls 2.7 million common shares, 8% of outstanding common shares of Fennec - MarketScreener

Dec 26, 2025
pulisher
Dec 26, 2025

Southpoint Trims Stake in Fennec Pharmaceuticals to 8% - TipRanks

Dec 26, 2025
pulisher
Dec 26, 2025

Southpoint holdings in Fennec Pharmaceuticals Inc. (TSX: FENC) - GlobeNewswire Inc.

Dec 26, 2025
pulisher
Dec 26, 2025

Why (FENC) Price Action Is Critical for Tactical Trading - Stock Traders Daily

Dec 26, 2025
pulisher
Dec 22, 2025

Adherex Technologies Inc. (NASDAQ:FENC) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat

Dec 22, 2025
pulisher
Dec 22, 2025

Adherex Technologies Inc. (NASDAQ:FENC) Given Consensus Recommendation of “Hold” by Analysts - Defense World

Dec 22, 2025
pulisher
Dec 21, 2025

Fennec Pharmaceuticals: A Compelling Single-Asset Growth Story For 2026 (NASDAQ:FENC) - Seeking Alpha

Dec 21, 2025
pulisher
Dec 19, 2025

Is Fennec Pharmaceuticals Inc. stock cheap at current valuation2025 Geopolitical Influence & Reliable Intraday Trade Plans - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Portfolio Update: How Fennec Pharmaceuticals Inc. stock trades before earningsWatch List & Risk Managed Trade Strategies - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

How Fennec Pharmaceuticals Inc. stock performs after earningsOptions Play & Advanced Swing Trade Entry Alerts - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Is Fennec Pharmaceuticals Inc. stock recession proofAnalyst Upgrade & Long-Term Safe Return Strategies - Улправда

Dec 19, 2025
pulisher
Dec 18, 2025

Can Fennec Pharmaceuticals Inc. (RV41) stock hold up in economic slowdownIPO Watch & Comprehensive Market Scan Insights - Улправда

Dec 18, 2025
pulisher
Dec 18, 2025

(FRX) Equity Trading Insights (FRX:CA) - Stock Traders Daily

Dec 18, 2025
pulisher
Dec 15, 2025

(FENC) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily

Dec 15, 2025
pulisher
Dec 15, 2025

Fennec Pharmaceuticals (TSX:FRX) Operate Today In Precision Oncology - Kalkine Media

Dec 15, 2025
pulisher
Dec 15, 2025

(FRX) Equity Market Report (FRX:CA) - Stock Traders Daily

Dec 15, 2025
pulisher
Dec 14, 2025

Fennec Pharmaceuticals (TSE:FRX) Insider Sells C$1,061,087.30 in Stock - MarketBeat

Dec 14, 2025

Fennec Pharmaceuticals Inc (FENC) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Fennec Pharmaceuticals Inc 주식 (FENC) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Andrade Robert
CHIEF FINANCIAL OFFICER
Jan 07 '26
Option Exercise
2.45
14,184
34,751
191,100
Raykov Rosty
Director
Jan 02 '26
Option Exercise
2.45
15,598
38,215
98,332
Raykov Rosty
Director
Jan 02 '26
Sale
7.60
10,312
78,371
88,020
$32.25
price down icon 4.73%
$106.21
price up icon 0.92%
$120.28
price down icon 2.43%
$109.00
price up icon 2.76%
$161.42
price up icon 1.35%
biotechnology ONC
$338.19
price down icon 0.03%
자본화:     |  볼륨(24시간):